tiprankstipranks
Trending News
More News >
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Revenue

Compare
688 Followers

Verve Therapeutics Revenue

Verve Therapeutics had a revenue of 32.98M in the quarter ending Mar 31, 2025, with 152.11%. This bring the company's revenue in the last twelve months to 59.61M, Decreased 84.38%. In the fiscal year ending Dec 31, 2024, Verve Therapeutics had annual revenue of 32.33M with 174.98% growth.
Revenue (ttm)
59.61M
Revenue Growth
271.44%
P/S Ratio
16.98
Revenue/Employee
$118,000
Employees
274
Market Cap
$549.12M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
32.33M20.57M+174.98%
Dec 31, 2023
11.76M9.82M+505.77%
Dec 31, 2022
1.94M+∞%
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis